<?xml version="1.0"?>
<Articles JournalTitle="Acta Medica Iranica">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>48</Volume>
      <Issue>5</Issue>
      <PubDate PubStatus="epublish">
        <Year>2010</Year>
        <Month>10</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Anti-mutagenic and Pro-apoptotic Effects of Apigenin on Human Chronic Lymphocytic Leukemia Cells</title>
    <FirstPage>283</FirstPage>
    <LastPage>288</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Mehrdad</FirstName>
        <LastName>Hashemi</LastName>
        <affiliation locale="en_US">Department of Genetics, Islamic Azad University, Tehran Medical Branch, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mehdi</FirstName>
        <LastName>Nouri Long</LastName>
        <affiliation locale="en_US">Department of Medicine, Islamic Azad University, Tehran medical Branch, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Maliheh</FirstName>
        <LastName>Entezari</LastName>
        <affiliation locale="en_US">Department of Genetics, Islamic Azad University, Tehran Medical Branch, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Shohreh</FirstName>
        <LastName>Nafisi</LastName>
        <affiliation locale="en_US">Department  of Chemistry, Islamic Azad University, Central Tehran Branch, Tehran, Iran. AND Research Institute for Islamic and Complementary Medicine, Iran University of Medical Science, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Hossein</FirstName>
        <LastName>Nowroozii</LastName>
        <affiliation locale="en_US">Research Institute for Islamic and Complementary Medicine, Iran University of Medical Science, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>09</Month>
        <Day>28</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Diet can play a vital role in cancer prevention. Nowadays the scientists are looking for food&#xA0;materials which can potentially prevent the cancer occurrence. The purpose of this research is to examine&#xA0;anti-mutagenic and apoptotic effects of apigenin in human lymphoma cells. In present study human chronic&#xA0;lymphocytic leukemia (Eheb cell line) were cultured in RPMI 1640 (Sigma), supplemented with 10% fetal&#xA0;calf serum, penicillin-streptomycin, L-glutamine and incubated at 37 &#xBA;C for 2 days. In addition cancer cell&#xA0;line was treated by and apigenin and cellular vital capacity was determined by MTT assay. Then effect of&#xA0;apigenin in human lymphoma B cells was examined by flow cytometry techniques. The apigenin was&#xA0;subsequently evaluated in terms of anti-mutagenic properties by a standard reverse mutation assay (Ames&#xA0;test). This was performed with histidine auxotroph strain of Salmonella typhimurium (TA100). Thus, it&#xA0;requires histidine from a foreign supply to ensure its growth. The aforementioned strain gives rise to reverted&#xA0;colonies when expose to sodium azide as a carcinogen substance. During MTT assay, human chronic&#xA0;lymphocytic leukemia revealed to have a meaningful cell death when compared with controls (P&lt;0.01)&#xA0;Apoptosis was induced suitably after 48 hours by flow cytometry assay. In Ames test apigenin prevented the&#xA0;reverted mutations and the hindrance percent of apigenin was 98.17%.These results have revealed apigenin&#xA0;induced apoptosis in human lymphoma B cells in vitro.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/4049</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/4049/4024</pdf_url>
  </Article>
</Articles>
